Member Info for Stan36

According to the TR1 Mavern had 3,136,463 shares as of 21 November when the threshold was crossed. This took them under 3%. There was significant selling after that and also the ostensibly precise trade mentioned by @humpalumps

Could be traders but whatever, the selling is much less now. This is moving significantly on relatively low volume.

It doesn't much matter, the fundamentals remain. Great buying opportunity. This could be suspended upon an announcement of an approach so I'm happily staying long my average price is 14.02p lowest paid was 11.99p. Would not be surprised to see an offer for £1/share. Small change for big pharma considering the technology. Patience is required 👌

B777 I'd like to change mine to £13.56 for year end. Not least because that's my average buy price 🤓

RE (& family) own 75m shares I recall. Ronjon must have factored this in. Unavoidable I assume unless we see a tr1 in next 2 days. Good buying opportunity if he sells them 🤠

Possibly Mavern selling still. May have held on to some shares thinking there'd be an NCI RNS to coincide with the Optimal commercial launch, and a big rise. Then impatience got the better of them....

Yes takeover looking increasingly likely. And possibly soon to avoid licencing being done to competitors of whoever buys them out. Might also partly explain the NCI extension delay. I'm holding on tight to my wage of shares.

Looks like we might smash through 1300 soon. Where's Pogo when you need him? 🤠

Yes I'm still.here and holding. Added more at 999 and 1040ish. I see DEShaw reduced short position 2 days ago. Small but significant buy back of 34,000 shares.

Early signs, steady genuine interest is required. Hopefully not traders. 2p by Christmas maybe 🌲

At current price of £12.35/share that's around £95m of buying required to close the shorts. Some still in profit because position taken out before June results at prices above 1600p. We're not out of the woods yet but the squeeze is approaching.

Great find @gtc1507. USA is more commercially orientated than UK. Huge potential with NCI and much else. I expect we will break into the 20s this week.

>25% off the bottom of 965p

Looks like we have turned. Although been to 1400 before from 980 and the shorters took it back down...

Institutions buy shares, lend to shorters who sell them. It's possible the same institution buys more and lends to shorters and so on. GameStop was famously shorted to 140% 🤓

At some stage over 7 million Wizz shares must be bought back.....

Airlines generally up.: RYA IAG EZJ JET2. But Wizz the most. Some shorts unwinding I guess.

And where's ego-pogo? His deramping rants often correlate with price rises too.

Er....VikR. 20m tranches? 🤔

Tick-up imminent methinks. NT to buy on AJ Bell

Never yield to the apparently overwhelming might of the enemy.

@VikR On ADVFN it's reported as a sell at 17.49p As is another trade 2 minutes later: 75,000 shares at 17.25p

My only concern, through ignorance, is what specifically does the patent protect. Is there a risk AI can in future work out optimum antibody design without affecting the patent?

Yes @offmessage me too but reading here and so s research convinced me it was largely the selling pressure due to Mavern offloading, plus possibly some impatient PIs. Now over 50% up from that recent low. With the best rise yet to come.